Fromsocial media”soft launches” to lingering “what are we?” conversations, unclear dating expectations have become a familiar part of modern relationships. As more users express fatigue with ambiguous connections, Xdate, a social dating app built around real-time interactions, today announced the launch of a new in-app feature designed to help users clarify intentions earlier in the […]
(Brussels:NYXH),(NasdaqGM:NYXH), Nyxoah Announces Commercial Launch of Genio(R) Breakthrough Therapy in the NetherlandsFirst Genio implants successfully performed at OLVG West and Zuyderland hospitals Mont-Saint-Guibert, Belgium – December 17, 2025, 7:05am CET / 1:05am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep
Nyxoah Announces Commercial Launch of Genio(R) Breakthrough Therapy in the Netherlands GlobeNewswire December 17, 2025 Nyxoah Announces Commercial Launch of Genio(R) Breakthrough Therapy in the NetherlandsFirst Genio implants successfully performed at OLVG West and Zuyderland hospitals Mont-Saint-Guibert, Belgium – December 17, 2025, 7:05am CET / 1:05am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or
AIxCrypto Inc. (NASDAQ: AIXC, “AIxC” or “the Company”) today announced the appointment of Andrew Grossman as Head of Legal. In this role, Andrew will direct the Company's legal, compliance, and governance functions, managing key areas including SEC disclosures, fund and investment compliance, digital asset and Web3 protocol architecture, and major strategic and commercial agreements. https://mma.prnewswire.com/media/2847468/AIxC_Appoints_Andrew_Grossman_as_Head_of_Legal.jpg
(Paris:SAN), Sanofi's efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema Additional orphan designation reinforces Sanofi's commitment to developing treatments for rare diseases Efdoralprin alfa, an investigational restorative recombinant therapy, recently met all primary and key secondary endpoints in phase 2 head-to-head study versus a plasma-derived standard of care Paris,
UK-based education multinationalGEDU Global Education has signed an agreement with the United Nations Institute for Training and Research (UNITAR), formally committing to operate one of its 32 international training centres located around the world. The mission of the training centres is to provide capacity building programmes that support the achievement of the 17 Sustainable Development
— Transition from An Asset-Heavy Business Model to An Asset-Light Business Model — Achieved Quarterly Non-GAAP Net Profitability — Maintained Non-GAAP Operational Profitability for Three Consecutive Quarters — Achieved Quarterly Positive Operating Cash Flow 111, Inc. (“111” or the “Company”) (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of
Recent employment data reveals heightened job market pressures affecting mental health needs. In light of these circumstances,LightingWay Counselling & Therapy continues to provide affordable therapy services to help Singaporeans cope better with a complex, evolving job market. https://mma.prnewswire.com/media/2847404/image_5005395_10046179.jpg Singaporeans Continue to Face Job Market Challenges Going into 2026 As artificial intelligence (AI) continues to reshape
Press Release: Sanofi's efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema GlobeNewswire December 17, 2025 Sanofi's efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema Additional orphan designation reinforces Sanofi's commitment to developing treatments for rare diseases Efdoralprin alfa, an investigational restorative recombinant therapy,
Reign is pleased to announce the upcoming opening of its non-partisan literary gallery, a dedicated public exhibition space preserving and presenting rare printed materials, original artifacts, and culturalephemera from defining moments in American civic life. The Gallery's inaugural exhibitions focus on Franklin D. Roosevelt's New Deal, with particular emphasis on the Civilian Conservation Corps, National